Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary Syndrome
Clinical trial NCT04652960 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04652960
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-10-21
- Primary completion
- 2026-12-03
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.